Casey Timmerman (Casey Moore)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Inflammatory Response

Radical Prostatectomy

Epidermal Growth Factor Receptor

Dendritic Cells

Top Venues

Nature biomedical engineering

Nature immunology

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Casey Timmerman, Isabel Naraine, Tian Zhang
Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation. The oncologist 29 (8) (2024)
Casey Timmerman, Isabel Naraine, Tian Zhang
Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation. The oncologist (2024)
Casey Timmerman, Isabel Naraine, Tian Zhang
Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation. The oncologist 29 (8) (2024)
Longchao Liu, Jiahui Chen, Joonbeom Bae, Huiyu Li, Zhichen Sun, Casey Timmerman, Eric J Hsu, Chuanhui Han, Jian Qiao, Yang-Xin Fu
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells. Nature biomedical engineering 5 (11) (2021)
Chuanhui Han, Zhida Liu, Yunjia Zhang, Aijun Shen, Chunbo Dong, Anli Zhang, Casey Timmerman, Zhenhua Ren, Changzheng Lu, Xuezhi Cao, Chun-Li Zhang, Jian Qiao, Yang-Xin Fu
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling. Nature immunology 21 (5) (2020)
Zhida Liu, Chuanhui Han, Chunbo Dong, Aijun Shen, Eric J Hsu, Zhenhua Ren, Changzheng Lu, Longchao Liu, Anli Zhang, Casey Timmerman, Yang Pu, Yang Wang, Mingyi Chen, Jian Qiao, Yang-Xin Fu
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity. Science immunology 4 (38) (2020)